Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection

Clinical and Vaccine Immunology

Volumn 20, Issue 1, 2013, Pages 17-23

  Alam, Mohammad Murshid ^a   Arifuzzaman, Mohammad ^a,e   Ahmad, Shaikh Meshbahuddin ^a   Hosen, M Ismail ^a   Rahman, Mohammad Arif ^a   Rashu, Rasheduzzaman ^a   Sheikh, Alaullah ^a,f   Ryan, Edward T ^b,c,d   Calderwood, Stephen B ^b,c   Qadri, Firdausi ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INACTIVATED VACCINE; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; VIBRIO CHOLERAE O1 LIPOPOLYSACCHARIDE;

ADULT; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CELL COUNT; CHOLERA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGICAL MEMORY; MALE; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIBRIO CHOLERAE;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; BANGLADESH; CHOLERA; CHOLERA TOXIN; CHOLERA VACCINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOLOGIC MEMORY; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; VIBRIO CHOLERAE O1; YOUNG ADULT;

EID: 84872256281     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00521-12     Document Type: Article

References (42)

1. Anonymous. 2011. WHO cholera fact sheet. WHO, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs107/en/index.html.
2. Koelle K, Rodo X, Pascual M, Yunus M, Mostafa G. 2005. Refractory periods and climate forcing in cholera dynamics. Nature 436:696-700.
3. Levine MM, Black RE, Clements ML, Cisneros L, Nalin DR, Young CR. 1981. Duration of infection-derived immunity to cholera. J. Infect. Dis. 143:818-820.
4. Anonymous. 2010. Cholera vaccines:WHOposition paper. Wkly. Epidemiol. Rec. 85:117-128.
5. Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, Ali M, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Donner A, Ganguly NK, Nair GB, Bhattacharya SK, Clemens JD. 2009. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet 374:1694-1702.
6. Harris JB, LaRocque RC, Chowdhury F, Khan AI, Logvinenko T, Faruque AS, Ryan ET, Qadri F, Calderwood SB. 2008. Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl Trop. Dis. 2:e221. doi:10.1371/journal.pntd.0000221.
7. Glass RI, Svennerholm AM, Khan MR, Huda S, Huq MI, Holmgren J. 1985. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J. Infect. Dis. 151:236-242.
8. Saha D, LaRocque RC, Khan AI, Harris JB, Begum YA, Akramuzzaman SM, Faruque AS, Ryan ET, Qadri F, Calderwood SB. 2004. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh. J. Infect. Dis. 189 :2318-2322.
9. Harris AM, Bhuiyan MS, Chowdhury F, Khan AI, Hossain A, Kendall EA, Rahman A, LaRocque RC, Wrammert J, Ryan ET, Qadri F, Calderwood SB, Harris JB. 2009. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect. Immun. 77:3850-3856.
10. Jayasekera CR, Harris JB, Bhuiyan S, Chowdhury F, Khan AI, Faruque AS, Larocque RC, Ryan ET, Ahmed R, Qadri F, Calderwood SB. 2008. Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. J. Infect. Dis. 198:1055-1061.
11. Asaduzzaman M, Ryan ET, John M, Hang L, Khan AI, Faruque AS, Taylor RK, Calderwood SB, Qadri F. 2004. The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139. Infect. Immun. 72:4448-4454.
12. Qadri F, Jonson G, Begum YA, Wenneras C, Albert MJ, Salam MA, Svennerholm AM. 1997. Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139. Clin. Diagn. Lab. Immunol. 4:429-434.
13. Qadri F, Mohi G, Hossain J, Azim T, Khan AM, Salam MA, Sack RB, Albert MJ, Svennerholm AM. 1995. Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin. Diagn. Lab. Immunol. 2:685-688.
14. Qadri F, Wenneras C, Albert MJ, Hossain J, Mannoor K, Begum YA, Mohi G, Salam MA, Sack RB, Svennerholm AM. 1997. Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect. Immun. 65:3571-3576.
15. Weil AA, Arifuzzaman M, Bhuiyan TR, LaRocque RC, Harris AM, Kendall EA, Hossain A, Tarique AA, Sheikh A, Chowdhury F, Khan AI, Murshed F, Parker KC, Banerjee KK, Ryan ET, Harris JB, Qadri F, Calderwood SB. 2009. Memory T-cell responses to Vibrio cholerae O1 infection. Infect. Immun. 77:5090-5096.
16. de Souza VA, Fernandes S, Araujo ES, Tateno AF, Oliveira OM, Oliveira RR, Pannuti CS. 2004. Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections. J. Clin. Microbiol. 42:1782-1784.
17. Pullen GR, Fitzgerald MG, Hosking CS. 1986. Antibody avidity determination by ELISA using thiocyanate elution. J. Immunol. Methods 86:83-87.
18. Hedman K, Rousseau SA. 1989. Measurement of avidity of specific IgG for verification of recent primary rubella. J. Med. Virol. 27:288-292.
19. Baccard-Longere M, Freymuth F, Cointe D, Seigneurin JM, Grangeot-Keros L. 2001. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity. Clin. Diagn. Lab. Immunol. 8:429-431.
20. Ward KN, Turner DJ, Parada XC, Thiruchelvam AD. 2001. Use of immunoglobulin G antibody avidity for differentiation of primary human herpesvirus 6 and 7 infections. J. Clin. Microbiol. 39:959-963.
21. de Souza VA, Pannuti CS, Sumita LM, de Andrade Junior HF. 1997. Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines. J. Med. Virol. 52:275-279.
22. Goldblatt D, Vaz AR, Miller E. 1998. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J. Infect. Dis. 177:1112-1115.
23. Usinger WR, Lucas AH. 1999. Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides. Infect. Immun. 67:2366-2370.
24. Narita M, Matsuzono Y, Takekoshi Y, Yamada S, Itakura O, Kubota M, Kikuta H, Togashi T. 1998. Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G. Clin. Diagn. Lab. Immunol. 5:799-803.
25. Alam MM, Riyadh MA, Fatema K, Rahman MA, Akhtar N, Ahmed T, Chowdhury MI, Chowdhury F, Calderwood SB, Harris JB, Ryan ET, Qadri F. 2011. Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera. Clin. Vaccine Immunol. 18:844-850.
26. Qadri F, Ahmed F, Karim MM, Wenneras C, Begum YA, Abdus Salam M, Albert MJ, McGhee JR. 1999. Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera. Clin. Diagn. Lab. Immunol. 6:812-818.
27. Ozkul A, Demir B, Karaoglu T, Alkan F, Dincer E, Oncel T, Burgu I. 2008. Maturation of immunoglobulin G avidity after inactive gE deleted bovine herpesvirus type 1 (BHV-1) marker vaccination. Viral Immunol. 21:3-11.
28. Bendall R, Ellis V, Ijaz S, Thurairajah P, Dalton HR. 2008. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J. Med. Virol. 80:95-101.
29. Crotty S, Aubert RD, Glidewell J, Ahmed R. 2004. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286:111-122.
30. Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R. 2003. Long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171:4969-4973.
31. Crotty S. 2011. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29:621-663.
32. Allen CD, Okada T, Cyster JG. 2007. Germinal-center organization and cellular dynamics. Immunity 27:190-202.
33. Arifuzzaman M, Rashu R, Leung DT, Hosen MI, Bhuiyan TR, Bhuiyan MS, Rahman MA, Khanam F, Saha A, Charles RC, Larocque RC, Weil AA, Clements JD, Holmes RK, Calderwood SB, Harris JB, Ryan ET, Qadri F. 2012. Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in bangladeshi children and comparison to responses in patients with naturally acquired cholera. Clin. Vaccine Immunol. 19:1304-1311.
34. Bergtold A, Desai DD, Gavhane A, Clynes R. 2005. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 23:503-514.
35. Peng SL. 2005. Signaling in B cells via Toll-like receptors. Curr. Opin. Immunol. 17:230-236.
36. Balazs M, Martin F, Zhou T, Kearney J. 2002. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17:341-352.
37. Batista FD, Iber D, Neuberger MS. 2001. B cells acquire antigen from target cells after synapse formation. Nature 411:489-494.
38. Kushnir N, Liu L, MacPherson GG. 1998. Dendritic cells and resting B cells form clusters in vitro and in vivo: T cell independence, partial LFA-1 dependence, and regulation by cross-linking surface molecules. J. Immunol. 160:1774-1781.
39. Qi H, Egen JG, Huang AY, Germain RN. 2006. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 312:1672-1676.
40. Cerutti A, Chen K, Chorny A. 2011. Immunoglobulin responses at the mucosal interface. Annu. Rev. Immunol. 29:273-293.
41. Cerutti A. 2008. The regulation of IgA class switching. Nat. Rev. Immunol. 8:421-434.
42. Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P. 2008. The immune geography of IgA induction and function. Mucosal Immunol. 1:11-22.